CASPeR Ranking #50
Nippon India Pharma Fund - Growth
NAV (Tue Jan 14 2025)
₹502
Returns (Since Inception)
17.59%
Category Average
17.78%
Rating
NA
Allocation and Holdings
Asset class
Weightage
Healthcare
60.97%
Get your personalized mutual fund portfolio in 2 minutes.
4.5Overall rating
Scheme Information
Fund name
Nippon India Pharma Fund - Growth
Minimum SIP
100
Risk Level
Very High Risk
AUM
₹8914.89 Cr
ISIN
INF204K01968
Inception Date
Jun 05 2004
Standard Deviation
15.138
Beta
0.92
Sharpe Ratio
0.825
Benchmark
S&P BSE Healthcare TR INR
Expense Ratio
1.800%
Exit Load
1% if redeemed or switched out on or before completion of 1 month from the date of allotment of units. Nil, thereafter.
Risk
Very High Risk
Investment Objective
The primary investment objective of the scheme is to seek to generate consistent returns by investing in equity and equity related or fixed income securities of Pharma and other associated companies.
Fund Managers
Sailesh Raj Bhan
Kinjal Desai
About the AMC
Nippon Life India Asset Management Ltd
Phone Number
022-6808 7000/18602660111Email Address
customercare@nipponindiaim.inCorporate Office Address
Nippon Life India Asset Management Limited,4th Floor, Tower A, Peninsula Business Park,,Ganapatrao Kadam Marg,,Lower Parel (W)Overall AUM
₹8914.89 Cr
Popular Hybrid Funds
View all funds
Popular Equity funds
View all Funds
Franklin India Equity Advantage Fund Direct Growth
₹3491.35 Cr
11.23%
SBI PSU Regular Growth
₹4572.13 Cr
29.49%
Nippon India ELSS Tax Saver Fund Direct Plan - Growth Option
₹15198.77 Cr
13.70%
Nippon India Multi Cap Fund - Direct Plan - Growth
₹39385.20 Cr
22.01%
Quant Focused fund Growth Option Direct Plan
₹1075.42 Cr
15.21%
Expert designed mutual fund portfolios
Mutual Funds are a smart way to grow your money. They can help you achieve your financial goals as they have the potential to generate higher-than-inflation returns.
subscribe to The Sunday Investor & impress
your coworkers with your finance insights
no promotions • no spam • only finance
